{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:23:05Z","timestamp":1787998985495,"version":"build-2784847793"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Research Funds of the Department of Rheumatology, Immunology and Allergology, University Hospital"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To characterize the effect of ultra-short glucocorticoids followed by Tocilizumab monotherapy on the intima-media thickness (IMT) in GCA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Eighteen GCA patients received 500\u2009mg for 3 consecutive days (total of 1500mg) i.v. methylprednisolone on days 0\u20132, followed by i.v. Tocilizumab (8\u2009mg\/kg) on day 3 and thereafter weekly s.c. Tocilizumab injections (162\u2009mg) over 52\u2009weeks. US of temporal (TAs), axillary (AAs) and subclavian (SAs) arteries was performed at baseline, on days 2\u20133, and at weeks 4, 8, 12, 24 and 52. The largest IMT of all segments and IMT at landmarks of AA\/SA were recorded. IMT was scaled by mean normal values and averaged. Each segment was classified according to diagnostic cut-offs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 18 GCA patients, 16 patients had TA and 6 had extracranial large artery involvement. The IMT showed a sharp decline on day 2\/3 in the TAs and AAs\/SAs. In TAs, this was followed by an increase to baseline levels at week 4 and a subsequent slow decrease, which was paralleled by decreasing symptoms and achievement of clinical remission. The AAs\/SAs showed a new signal of vasculitis at week 4 in three patients, with an IMT increase up to week 8.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Glucocorticoid pulse therapy induced a transient decrease of the IMT in TAs and AAs\/SAs. Tocilizumab monotherapy resulted in a slow and steady decrease in IMT of the TAs and a smaller and delayed effect on the AAs\/SAs. The data strongly support a remission-inducing effect of Tocilizumab and argue the case for US having an important role in monitoring disease activity in GCA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration<\/jats:title>\n                  <jats:p>ClinicalTrials.gov, www.clinicaltrials.gov, NCT03745586.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab484","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T11:33:12Z","timestamp":1623324792000},"page":"5052-5059","source":"Crossref","is-referenced-by-count":57,"title":["Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5051-1445","authenticated-orcid":false,"given":"Luca","family":"Seitz","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, Bern University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Christ","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, Bern University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"L\u00f6tscher","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, Bern University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godehard","family":"Scholz","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, Bern University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela-Cristina","family":"Sarbu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, Bern University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"B\u00fctikofer","sequence":"additional","affiliation":[{"name":"CTU Bern, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8172-1285","authenticated-orcid":false,"given":"Florian","family":"Kollert","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, Bern University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang A","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Medical Centre for Rheumatology, Immanuel Krankenhaus Berlin, Berlin-Buch, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8098-6567","authenticated-orcid":false,"given":"Stephan","family":"Reichenbach","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, Bern University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8859-9964","authenticated-orcid":false,"given":"Peter M","family":"Villiger","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, Bern University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,2]]},"reference":[{"key":"2021110402573427200_keab484-B1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021110402573427200_keab484-B2","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","article-title":"Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Villiger","year":"2016","journal-title":"Lancet"},{"key":"2021110402573427200_keab484-B3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"key":"2021110402573427200_keab484-B4","author":"Christ","year":"2021"},{"key":"2021110402573427200_keab484-B5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021110402573427200_keab484-B6","doi-asserted-by":"crossref","first-page":"e000598","DOI":"10.1136\/rmdopen-2017-000598","article-title":"Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group","volume":"4","author":"Chrysidis","year":"2018","journal-title":"RMD Open"},{"key":"2021110402573427200_keab484-B7","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3899\/jrheum.171428","article-title":"Assessing vasculitis in giant cell arteritis by ultrasound: results of OMERACT patient-based reliability exercises","volume":"45","author":"Sch\u00e4fer","year":"2018","journal-title":"J Rheumatol"},{"key":"2021110402573427200_keab484-B8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11926-020-00955-y","article-title":"Imaging for diagnosis, monitoring, and outcome prediction of large vessel vasculitides","volume":"22","author":"Sch\u00e4fer","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"2021110402573427200_keab484-B9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/rheumatology\/key015","article-title":"Magnetic resonance angiography in giant cell arteritis: results of a randomized controlled trial of tocilizumab in giant cell arteritis","volume":"57","author":"Reichenbach","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2021110402573427200_keab484-B10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/art.40379","article-title":"18F-fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis","volume":"70","author":"Grayson","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2021110402573427200_keab484-B11","first-page":"S34","article-title":"The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arteritis","volume":"30","author":"De Miguel","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2021110402573427200_keab484-B12","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/rheumatology\/key383","article-title":"Vessel wall plasticity in large vessel giant cell arteritis: an ultrasound follow-up study","volume":"58","author":"Aschwanden","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2021110402573427200_keab484-B13","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/rheumatology\/kex143","article-title":"Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis","volume":"56","author":"Sch\u00e4fer","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2021110402573427200_keab484-B14","first-page":"128","article-title":"B-mode sonography wall thickness assessment of the temporal and axillary arteries for the diagnosis of giant cell arteritis: a cohort study","volume":"35(Suppl 103","author":"Czihal","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2021110402573427200_keab484-B15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/rheumatology\/kex381","article-title":"Atherosclerosis as a potential pitfall in the diagnosis of giant cell arteritis","volume":"57","author":"De Miguel","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2021110402573427200_keab484-B16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/annrheumdis-2019-216343","article-title":"Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia","volume":"79","author":"Van der Geest","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021110402573427200_keab484-B17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s41927-020-00136-5","article-title":"Halo score (temporal artery, its branches and axillary artery) as a diagnostic, prognostic and disease monitoring tool for giant cell arteritis (GCA)","volume":"4","author":"Sebastian","year":"2020","journal-title":"BMC Rheumatol"},{"key":"2021110402573427200_keab484-B18","article-title":"The cut-off values for the intima-media complex thickness assessed by colour Doppler sonography in seven cranial and aortic arch arteries","volume":"60","author":"Je\u0161e","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2021110402573427200_keab484-B19","doi-asserted-by":"crossref","first-page":"e001417","DOI":"10.1136\/rmdopen-2020-001417","article-title":"Efficacy and safety of tocilizumab in giant cell arteritis: a single centre NHS experience using imaging (ultrasound and PET-CT) as a diagnostic and monitoring tool","volume":"6","author":"Sebastian","year":"2020","journal-title":"RMD Open"},{"key":"2021110402573427200_keab484-B20","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1093\/rheumatology\/keaa196","article-title":"Early variation of ultrasound halo sign with treatment and relation with clinical features in patients with giant cell arteritis","volume":"59","author":"Ponte","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2021110402573427200_keab484-B21"},{"key":"2021110402573427200_keab484-B22","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/rheumatology\/kes153","article-title":"Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis","volume":"51","author":"Hauenstein","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2021110402573427200_keab484-B23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrrheum.2014.127","article-title":"IL-6 biology: implications for clinical targeting in rheumatic disease","volume":"10","author":"Calabrese","year":"2014","journal-title":"Nat Rev Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab484\/40500955\/keab484.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/11\/5052\/41073094\/keab484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/11\/5052\/41073094\/keab484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T02:58:02Z","timestamp":1635994682000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/11\/5052\/6297231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,2]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,10,2]]},"published-print":{"date-parts":[[2021,11,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab484","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,10,2]]}}}